MedPath

Morningside Healthcare Ltd.

Morningside Healthcare Ltd. logo
🇬🇧United Kingdom
Ownership
Subsidiary
Established
2001-01-01
Employees
101
Market Cap
-
Website
http://www.morningsidehealthcare.com

Clinical Trials

10

Active:0
Completed:8

Trial Phases

2 Phases

Phase 3:2
Not Applicable:4

Drug Approvals

76

EMC:76

Drug Approvals

Topiramate 200 mg Film-coated tablets

Approval Date
Jul 7, 2025
EMC

Hydrocortisone 5mg Dispersible Tablets

Approval Date
Jul 7, 2025
EMC

Akizza 75mcg /30 mcg tablets

Approval Date
Jul 7, 2025
EMC

Emerres 1.5 mg tablet

Approval Date
Jul 7, 2025
EMC

Propylthiouracil 100mg Tablets

Approval Date
Jul 7, 2025
EMC

Nitrofurantoin 100 mg capsules

Approval Date
Jul 7, 2025
EMC

Trifluoperazine 1 mg tablets

Approval Date
Jul 7, 2025
EMC

Nitrofurantoin 50 mg capsules

Approval Date
Jul 7, 2025
EMC

Glycopyrronium Bromide 2mg Tablets

Approval Date
Jul 7, 2025
EMC

Fluoxetine 20 mg hard capsules

Approval Date
Jul 7, 2025
EMC
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (66.7%)
Phase 3
2 (33.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.